Press release
Animal Nutrition
November 3, 2010

Evonik announces global price increase for L-Threonine

The Health & Nutrition Business Unit of Evonik Industries AG (Germany), announces a global price increase for L-Threonine 98.5% feed grade.

Effective immediately, the company increases its L-Threonine net price for full truck and container loads by €0.19/kg for all non-contract customers. Depending on logistic costs and exchange rates the actual selling price may vary by world areas.

The main reasons are the continuing rise in fermentation costs driven by the sharp increase of key raw material prices in the last six months.

All existing commitments and supply contracts will be honored and are unaffected by this price increase.

Evonik is the only company in the world that produces and markets all four essential amino acids used in advanced animal nutrition: DL-Methionine, Biolys® (L-lysine), L-Threonine and L-Tryptophan. The company markets innovative products and services in more than one hundred countries and thus makes a valuable contribution to the cost-efficiency of its customers and to healthy and environment-friendly animal nutrition.

About Evonik

Evonik Industries is the creative industrial group from Germany. In our core business of specialty chemicals, we are a global leader. In addition, Evonik is an expert in power generation from hard coal and renewable energies, and one of the largest private residential real estate companies in Germany. Our company’s performance is shaped by creativity, specialization, continuous self-renewal, and reliability.

Evonik is active in over 100 countries around the world. In its fiscal year 2009 about 39,000 employees generated sales of about €13.1 billion and an operating profit (EBITDA) of about €2.0 billion.


In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.